Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Impact of Cytoreductive Therapy and Depth of Response before Allogeneic Transplantation for Advanced Myelodysplastic Syndrome

Yu Wang, Lan-Ping Xu, Kaiyan Liu, MD PhD, Xiao-Hui Zhang, Chen-hua Yan, Xiao-Jun Huang, MD

Blood (2019) 134 (Supplement_1): 4607.

https://doi.org/10.1182/blood-2019-124046

Published: 2019

Journal Articles

Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

Xingxing Yu, Xiangyu Zhao, Xunhong Cao, Xuefei Liu, Xuying Pei, PhD, Xiaosu Zhao, Ying-Jun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, MD PhD, Xiao Jun Huang

Blood (2018) 132 (Supplement 1): 360.

https://doi.org/10.1182/blood-2018-99-115772

Published: 2018

Journal Articles

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Lijuan Hu, Qi Wang, PhD, Xiaohui Zhang, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Kaiyan Liu, MD PhD, Hui Wang, PhD, Xiaojun Huang, MD, Xiao-Dong Mo

Blood (2018) 132 (Supplement 1): 5757.

https://doi.org/10.1182/blood-2018-99-109858

Published: 2018

Journal Articles

Prophylactic Intervention with N-Acetyl-L-Cysteine before Allotransplant Could Reduce the Occurrence of Poor Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Yuan Kong, MD PhD, Yu Wang, Yuan-Yuan Zhang, Min-Min Shi, Xiao-Dong Mo, Yu-Qian Sun, MD, Ying-Jun Chang, Lan-Ping Xu, Xiaohui Zhang, MD, Kaiyan Liu, MD PhD, Xiao-Jun Huang

Blood (2018) 132 (Supplement 1): 2074.

https://doi.org/10.1182/blood-2018-99-111652

Published: 2018

Journal Articles

Haplo-SCT Mediates Stronger GVL Effect Than HLA-Matched Sibling Allograft By Significantly Reducing Leukemia Burden

Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Huan Chen, Chen-Hua Yan, Kaiyan Liu, MD PhD, Xiao-Jun Huang

Blood (2018) 132 (Supplement 1): 2186.

https://doi.org/10.1182/blood-2018-99-118409

Published: 2018

Journal Articles

Myeloid-Derived Suppressor Cells (HLA-DR -/low CD16 - CD33 + ) Expanded By Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT

Ke Wang, Meng Lv, Ying-Jun Chang, Xiang-Yu Zhao, Xiao-Su Zhao, Yuan-Yuan Zhang, Yu-Qian Sun, MD, Zhi-Dong Wang, Pan Suo, Yang Zhou, Dan Liu, Shu-Zhen Zhai, Yan Hong, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kaiyan Liu, MD PhD, Xiao-Jun Huang

Blood (2018) 132 (Supplement 1): 72.

https://doi.org/10.1182/blood-2018-99-114291

Published: 2018

Journal Articles

First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

Xiangyu Zhao, Xuying Pei, PhD, Xiaojun Huang, Ying-Jun Chang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, MD PhD

Blood (2018) 132 (Supplement 1): 727.

https://doi.org/10.1182/blood-2018-99-113923

Published: 2018

Journal Articles

Occurrence and Severity of DLI Associated Chronic Gvhd Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Wenjing Yu, MD, Xiao-Dong Mo, Xiaohui Zhang, MD, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kaiyan Liu, MD PhD, Xiaojun Huang

Blood (2018) 132 (Supplement 1): 3412.

https://doi.org/10.1182/blood-2018-99-110670

Published: 2018

Journal Articles

Donor and Recipient HLA Class I Molecule Are Required for Maximum NK Cells Cytotoxicity Reconstitution Post Haploidentical Hematopoietic Stem Cells Transplantation

Xiangyu Zhao, MD, PhD, Xingxing Yu, Mingrui Huo, Xiaosu Zhao, Xueyi Luo, Yingjun Chang, Xiaohui Zhang, MD, Lanping Xu, Kaiyan Liu, MD, PhD, Xiao-Jun Huang, MD

Blood (2017) 130 (Supplement 1): 3257.

https://doi.org/10.1182/blood.V130.Suppl_1.3257.3257

Published: 2017

Journal Articles

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Lanping Xu, Daihong Liu, Kaiyan Liu, MD, Chunli Zhang, Fengrong Wang, Jingzhi Wang, Yu Wang, MD, Huan Chen, Yuanyuan Zhang, Chenhua Yan, Wei Han, MD, Yuhong Chen, MD, PhD, Ting Zhao, Xiao-Hui Zhang, Xiaojun Huang

Blood (2012) 120 (21): 4512.

https://doi.org/10.1182/blood.V120.21.4512.4512

Published: 2012

Journal Articles

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Yuan Kong, MD, PhD, Yanrong Liu, MD, Honghu Zhu, PhD, Qian Jiang, MD, Hao Jiang, MD, Lan-Ping Xu, MD, Dai-Hong Liu, MD, PhD, Guo-Rui Ruan, PhD, Bin Jiang, MD, Kaiyan Liu, MD, Xiao-jun Huang, MD, PhD

Blood (2012) 120 (21): 1397.

https://doi.org/10.1182/blood.V120.21.1397.1397

Published: 2012

Journal Articles

Combined Use of WT1 and Flow Cytometry Monitoring Can Promote Sensitivity of Predicting Relapse After Allogeneic HSCT without Affecting Specificity.

Xiaosu Zhao, Chenhua Yan, Daihong Liu, Lanping Xu, Yanrong Liu, Kaiyan Liu, MD, Yazhen Qin, Yu Wang, MD, Xiaojun Huang

Blood (2012) 120 (21): 3065.

https://doi.org/10.1182/blood.V120.21.3065.3065

Published: 2012

Journal Articles

Superiority of Haploidentical Related Hematopoietic Stem-Cell Transplantation Over Chemotherapy Alone for Patients with Intermediate- or Poor- Risk Acute Myeloid Leukemia in First Complete Remission,

Yingjun Chang, Honghu Zhu, Lanping Xu, Hao Jiang, MD, Daihong Liu, Qian Jiang, Kaiyan Liu, MD, PhD, Jin Lu, MD, Bin Jiang, Xiaojun Huang

Blood (2011) 118 (21): 4161.

https://doi.org/10.1182/blood.V118.21.4161.4161

Published: 2011

Journal Articles

Pre-Emptive Therapy with Modified Donor Lymphocyte Infusion Could Reduce Relapse and Improve Survival in Standard-Risk Acute Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation

Chenhua Yan, Daihong Liu, Lanping Xu, Kaiyan Liu, MD, PhD, Huan Chen, Wei Han, Yu Wang, Xiaojun Huang

Blood (2011) 118 (21): 659.

https://doi.org/10.1182/blood.V118.21.659.659

Published: 2011

Journal Articles

Prolonged Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Association with Reduced Ploidy and Immaturation of Megakaryocytes

Xiao-hui Zhang, Haixia Fu, Lan-Ping Xu, Dai-Hong Liu, Kaiyan Liu, MD, PhD, Xiao Jun Huang, M.D, and, professor

Blood (2010) 116 (21): 4695.

https://doi.org/10.1182/blood.V116.21.4695.4695

Published: 2010

Journal Articles

Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kaiyan Liu, MD, PhD, Shan-Shan Chen, Bin Jiang, MD, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Xiao Jun Huang

Blood (2010) 116 (21): 2347.

https://doi.org/10.1182/blood.V116.21.2347.2347

Published: 2010

NARROW

Impact of Cytoreductive Therapy and Depth of Response before Allogeneic Transplantation for Advanced Myelodysplastic Syndrome

Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Prophylactic Intervention with N-Acetyl-L-Cysteine before Allotransplant Could Reduce the Occurrence of Poor Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Haplo-SCT Mediates Stronger GVL Effect Than HLA-Matched Sibling Allograft By Significantly Reducing Leukemia Burden

Myeloid-Derived Suppressor Cells (HLA-DR -/low CD16 - CD33 + ) Expanded By Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT

First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

Occurrence and Severity of DLI Associated Chronic Gvhd Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Donor and Recipient HLA Class I Molecule Are Required for Maximum NK Cells Cytotoxicity Reconstitution Post Haploidentical Hematopoietic Stem Cells Transplantation

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Combined Use of WT1 and Flow Cytometry Monitoring Can Promote Sensitivity of Predicting Relapse After Allogeneic HSCT without Affecting Specificity.

Superiority of Haploidentical Related Hematopoietic Stem-Cell Transplantation Over Chemotherapy Alone for Patients with Intermediate- or Poor- Risk Acute Myeloid Leukemia in First Complete Remission,

Pre-Emptive Therapy with Modified Donor Lymphocyte Infusion Could Reduce Relapse and Improve Survival in Standard-Risk Acute Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation

Prolonged Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Association with Reduced Ploidy and Immaturation of Megakaryocytes

Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only